Zepp Health Statistics
Total Valuation
Zepp Health has a market cap or net worth of $133.01 million. The enterprise value is $196.72 million.
Important Dates
The next estimated earnings date is Wednesday, May 20, 2026, after market close.
| Earnings Date | May 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zepp Health has 14.66 million shares outstanding. The number of shares has decreased by -1.72% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 14.66M |
| Shares Change (YoY) | -1.72% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 35.24% |
| Owned by Institutions (%) | 25.76% |
| Float | 6.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 89.45 |
| PS Ratio | 0.53 |
| Forward PS | n/a |
| PB Ratio | 0.73 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.02 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.13 |
Financial Efficiency
Return on equity (ROE) is -17.15% and return on invested capital (ROIC) is -10.66%.
| Return on Equity (ROE) | -17.15% |
| Return on Assets (ROA) | -3.34% |
| Return on Invested Capital (ROIC) | -10.66% |
| Return on Capital Employed (ROCE) | -10.51% |
| Weighted Average Cost of Capital (WACC) | 10.03% |
| Revenue Per Employee | $339,315 |
| Profits Per Employee | -$52,514 |
| Employee Count | 763 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.47 |
Taxes
In the past 12 months, Zepp Health has paid $2.54 million in taxes.
| Income Tax | 2.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +231.12% in the last 52 weeks. The beta is 2.02, so Zepp Health's price volatility has been higher than the market average.
| Beta (5Y) | 2.02 |
| 52-Week Price Change | +231.12% |
| 50-Day Moving Average | 14.40 |
| 200-Day Moving Average | 28.60 |
| Relative Strength Index (RSI) | 32.38 |
| Average Volume (20 Days) | 96,431 |
Short Selling Information
The latest short interest is 354,079, so 5.51% of the outstanding shares have been sold short.
| Short Interest | 354,079 |
| Short Previous Month | 463,069 |
| Short % of Shares Out | 5.51% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.31 |
Income Statement
In the last 12 months, Zepp Health had revenue of $258.90 million and -$40.07 million in losses. Loss per share was -$2.56.
| Revenue | 258.90M |
| Gross Profit | 99.19M |
| Operating Income | -29.23M |
| Pretax Income | -37.53M |
| Net Income | -40.07M |
| EBITDA | -24.70M |
| EBIT | -29.23M |
| Loss Per Share | -$2.56 |
Full Income StatementBalance Sheet
The company has $57.05 million in cash and $117.24 million in debt, with a net cash position of -$60.19 million or -$4.10 per share.
| Cash & Cash Equivalents | 57.05M |
| Total Debt | 117.24M |
| Net Cash | -60.19M |
| Net Cash Per Share | -$4.10 |
| Equity (Book Value) | 214.53M |
| Book Value Per Share | 14.61 |
| Working Capital | 6.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$25.69 million and capital expenditures -$516,000, giving a free cash flow of -$26.21 million.
| Operating Cash Flow | -25.69M |
| Capital Expenditures | -516,000 |
| Depreciation & Amortization | 4.54M |
| Net Borrowing | 27.14M |
| Free Cash Flow | -26.21M |
| FCF Per Share | -$1.79 |
Full Cash Flow StatementMargins
Gross margin is 38.31%, with operating and profit margins of -11.29% and -15.48%.
| Gross Margin | 38.31% |
| Operating Margin | -11.29% |
| Pretax Margin | -14.50% |
| Profit Margin | -15.48% |
| EBITDA Margin | -9.54% |
| EBIT Margin | -11.29% |
| FCF Margin | n/a |
Dividends & Yields
Zepp Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.72% |
| Shareholder Yield | 1.72% |
| Earnings Yield | -29.35% |
| FCF Yield | -19.20% |
Analyst Forecast
The average price target for Zepp Health is $56.28, which is 520.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56.28 |
| Price Target Difference | 520.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 16, 2024. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
Zepp Health has an Altman Z-Score of 0.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.72 |
| Piotroski F-Score | 3 |
